Sarcoidosis of lung
ICD-10 D86.0 is a billable code used to indicate a diagnosis of sarcoidosis of lung.
Sarcoidosis of the lung is a systemic granulomatous disease characterized by the formation of non-caseating granulomas in various organs, predominantly the lungs. The etiology remains unclear, but it is believed to involve an exaggerated immune response to environmental antigens in genetically predisposed individuals. Clinically, patients may present with respiratory symptoms such as cough, dyspnea, and chest pain, alongside systemic manifestations like fatigue, fever, and weight loss. Diagnosis typically involves imaging studies, such as chest X-rays or CT scans, which may reveal bilateral hilar lymphadenopathy or pulmonary infiltrates. Definitive diagnosis often requires histological confirmation through bronchoscopy or lung biopsy. The disease can lead to complications such as pulmonary fibrosis, respiratory failure, and increased risk of lung infections. Management may include corticosteroids and immunosuppressive agents, particularly in cases with significant pulmonary involvement or extrapulmonary manifestations. Regular monitoring of lung function and imaging is essential to assess disease progression and treatment response.
Detailed pulmonary function tests, imaging results, and biopsy reports.
Patients presenting with unexplained cough, dyspnea, or abnormal chest X-ray findings.
Ensure clear documentation of the extent of lung involvement and any associated complications.
Comprehensive assessment of systemic symptoms and organ involvement.
Patients with sarcoidosis presenting with joint pain or skin lesions.
Document any extrapulmonary manifestations and their management.
Used for obtaining lung biopsy in suspected sarcoidosis cases.
Document indication for bronchoscopy and findings.
Pulmonologists should ensure clear documentation of the procedure and results.
The primary treatment for sarcoidosis of the lung is corticosteroids, which help reduce inflammation and granuloma formation. In cases of severe or persistent symptoms, immunosuppressive agents may also be used.
